SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · IEX Real-Time Price · USD
5.08
-0.02 (-0.39%)
May 2, 2024, 4:30 PM EDT - Market closed

SOPHiA GENETICS Revenue

In the year 2023, SOPHiA GENETICS had annual revenue of $62.37M with 31.14% growth. Revenue in the quarter ending December 31, 2023 was $17.05M with 27.38% year-over-year growth.

Revenue (ttm)
$62.37M
Revenue Growth
+31.14%
P/S Ratio
5.32
Revenue / Employee
$145,049
Employees
430
Market Cap
331.73M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202362.37M14.81M31.14%
Dec 31, 202247.56M7.11M17.58%
Dec 31, 202140.45M12.05M42.43%
Dec 31, 202028.40M3.04M11.98%
Dec 31, 201925.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.76B
Tactile Systems Technology 274.42M
Esperion Therapeutics 116.33M
CVRx, Inc. 39.30M
Precigen 6.23M
Immutep 4.58M
Q32 Bio 1.16M
Revenue Rankings